Overview

Pilot Test of ACTOS in Multiple Sclerosis: Safety and Tolerability

Status:
Completed
Trial end date:
2005-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether an already FDA approved drug is safe and tolerable in Relapsing Remitting Multiple Sclerosis patients.
Phase:
Phase 1
Details
Lead Sponsor:
University of Illinois at Chicago
Collaborator:
Takeda Pharmaceuticals North America, Inc.
Treatments:
Pioglitazone